You are here

Article Text

Article menu
Download PDFPDF
Case report
Omalizumab-associated eosinophilic granulomatosis with polyangiitis: cause or coincidence?

Abstract

Omalizumab is an anti-IgE monoclonal antibody used in severe allergic asthma. Herein, we describe a case of eosinophilic granulomatosis with polyangiitis, which manifested 3 months after initiation of omalizumab therapy, while maintenance corticosteroid therapy dose was unchanged.

  • asthma
  • drugs: respiratory system
  • vasculitis
  • respiratory system

https://doi.org/10.1136/bcr-2020-240078

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.